-
673293-250MG
PENTAMETHYLCYCLOPENTADIENYLBIS(TRIPHENYLPHOSPHINE) RUTHENIUM(II) CHLORIDE (C005B-090312)
Price: $263.08List Price: $292.31Application Catalyst employed in the cycloaddtion of azides with acetylenes giving exclusively the 1,5-disubstitutedtriazoles in contrast to the 1,4-regiochemistry commonly observed with copper catalysis. Ruthenium catalysis also enables the use of -
P488811-1g
Pentamethylcyclopentadienylbis(triphenylphosphine)ruthenium(II) chloride (C007B-251590)
Price: $55.80List Price: $62.00DescriptionCatalyst employed in the cycloaddtion of azides with acetylenes giving exclusively the 1,5-disubstitutedtriazoles in contrast to the 1,4-regiochemistry commonly observed with copper catalysis. Ruthenium catalysis also enables the use of -
P488811-250mg
Pentamethylcyclopentadienylbis(triphenylphosphine)ruthenium(II) chloride (C007B-251591)
Price: $21.80List Price: $24.22DescriptionCatalyst employed in the cycloaddtion of azides with acetylenes giving exclusively the 1,5-disubstitutedtriazoles in contrast to the 1,4-regiochemistry commonly observed with copper catalysis. Ruthenium catalysis also enables the use of -
P488811-5g
Pentamethylcyclopentadienylbis(triphenylphosphine)ruthenium(II) chloride (C007B-251592)
Price: $2,339.88List Price: $2,599.87DescriptionCatalyst employed in the cycloaddtion of azides with acetylenes giving exclusively the 1,5-disubstitutedtriazoles in contrast to the 1,4-regiochemistry commonly observed with copper catalysis. Ruthenium catalysis also enables the use of -
R648127-10mg
Rovazolac (C007B-415722)
Price: $355.32List Price: $394.80Rovazolac is a liver x receptor (LXR) modulator extracted from patent WO2013130892A1.In VitroRovazolac is an anti-inflammatory drug candidate. MCE has not independently confirmed the accuracy of these methods. They are for reference